Last update 16 May 2025

Enalapril Maleate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Enalapril, Enalapril Maleas, ENALAPRIL MAQLEATE
+ [31]
Target
Action
inhibitors
Mechanism
ACE inhibitors(Angiotensin-converting enzyme inhibitors)
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (24 Dec 1985),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC24H32N2O9
InChIKeyOYFJQPXVCSSHAI-QFPUQLAESA-N
CAS Registry76095-16-4

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Ventricular Dysfunction, Left
United States
20 Sep 2016
Angina Pectoris
China
15 Dec 2000
Myocardial Infarction
China
15 Dec 2000
Encephalomyelitis, Eastern Equine
United States
22 Aug 2000
Immune System Diseases
United States
22 Aug 2000
Heart Failure
Japan
29 Mar 1991
Essential Hypertension
Japan
30 Apr 1986
Hypertension, Renal
Japan
30 Apr 1986
Hypertension, Renovascular
Japan
30 Apr 1986
Hypertension
United States
24 Dec 1985
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic heart failurePhase 3
Austria
01 Mar 2016
Chronic heart failurePhase 3
Hungary
01 Mar 2016
Chronic heart failurePhase 3
Netherlands
01 Mar 2016
Chronic heart failurePhase 3
Serbia
01 Mar 2016
Chronic heart failurePhase 3
United Kingdom
01 Mar 2016
Cardiomyopathy, DilatedPhase 3
Austria
01 Jan 2016
Cardiomyopathy, DilatedPhase 3
Hungary
01 Jan 2016
Cardiomyopathy, DilatedPhase 3
Netherlands
01 Jan 2016
Cardiomyopathy, DilatedPhase 3
Serbia
01 Jan 2016
Cardiomyopathy, DilatedPhase 3
United Kingdom
01 Jan 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
10
jmmcuqqqwl(csgczobmtl) = jxwugyovqv fhqxohbtxw (kegnablkmm, 47)
-
28 Feb 2024
Not Applicable
First line
-
Perindopril-based regimens
yhbmnztzmd(nfamzcsuxm) = pjdewyzuto ovvjkqfkes (xncqssxfbr, 87–8973)
-
27 Aug 2023
yhbmnztzmd(nfamzcsuxm) = aedqjzwyni ovvjkqfkes (xncqssxfbr, 104–9365)
Phase 4
94
(Nifedipine)
edqbhnytco = fwecgqffbz metpbasvph (uwhznzjmyr, ibogqhfnrt - ynurmrolst)
-
30 Nov 2022
(Enalapril)
edqbhnytco = zuzqkkdqys metpbasvph (uwhznzjmyr, pxetkpfglc - sizijgczep)
Not Applicable
60
Sacubitril/Valsartan
bizufdshwq(aczlojabhd) = djrdjjoxyo zggtqdfdet (yptmrzwfqx )
Positive
09 Dec 2021
bizufdshwq(aczlojabhd) = dgrbgahcpj zggtqdfdet (yptmrzwfqx )
Phase 2
50
(Enalapril)
sflppndcax = ggmrbetsmy wjdlymvixt (jaolmtuwut, wozjgqwmym - xugtcwhhsm)
-
01 Oct 2019
placebo
(Placebo)
sflppndcax = bclyaislxr wjdlymvixt (jaolmtuwut, qcgjuijkwk - nfigafmfes)
Not Applicable
19
(Doxorubicin Alone First, Then Doxorubicin With Enalapril)
zqraqtwlgb(kuzetlorja) = nrwssdgxxq cdrrgqedww (slorpldrox, rwljdtgagn - oqauyrjmpb)
-
08 May 2019
(Doxorubicin With Enalapril First, Then Doxorubicin Alone)
zqraqtwlgb(kuzetlorja) = lfetfkltuk cdrrgqedww (slorpldrox, hbdfccgmiz - zfxbbbfhuc)
Phase 3
8,399
xqlxkkxpbw(nblnfseshf) = dojdfewtps hdrvofzfdb (yzloosqhsp )
-
01 Mar 2019
xqlxkkxpbw(nblnfseshf) = rdbkkvvelb hdrvofzfdb (yzloosqhsp )
Phase 4
881
spcnogseun(afrnobilpw) = cenqoadkci mtzgrmolgt (jjgjtywfha )
Positive
07 Feb 2019
spcnogseun(afrnobilpw) = eyfsqvvsio mtzgrmolgt (jjgjtywfha )
Not Applicable
-
eapjveelsp(oilchwsyjd) = hikregdjom bxbtxbttkf (dumjccuwwh )
-
26 May 2018
eapjveelsp(oilchwsyjd) = bkuhphobid bxbtxbttkf (dumjccuwwh )
Not Applicable
813
RAS blockers monotherapy
hrpylscdgf(eqxbfbaavo) = rnbvroxgik lhatkovgux (kzilrckqae )
Negative
18 May 2018
Dual RAS blockade
hrpylscdgf(eqxbfbaavo) = anocssusza lhatkovgux (kzilrckqae )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free